Compare · NH vs VRSN
NH vs VRSN
Side-by-side comparison of NantHealth Inc. (NH) and VeriSign Inc. (VRSN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both NH and VRSN operate in EDP Services (Technology), so they compete in similar markets.
- VRSN is the larger of the two at $26.99B, about 303.6x NH ($88.9M).
- VRSN has hit the wire 17 times in the past 4 weeks while NH has been quiet.
- VRSN has more recent analyst coverage (7 ratings vs 0 for NH).
- Company
- NantHealth Inc.
- VeriSign Inc.
- Price
- -
- -
- Market cap
- $88.9M
- $26.99B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- EDP Services
- EDP Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2016
- 1998
- News (4w)
- 0
- 17
- Recent ratings
- 0
- 7
NantHealth Inc.
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States and internationally. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform's comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans and CMS for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks. In addition, it offers GPS Cancer, a comprehensive molecular profile that integrates whole genome/exome (DNA) sequencing of tumor and normal germline samples and whole transcriptome (RNA) sequencing; Omics Core, an in-vitro diagnostic built on a custom-targeted whole exome sequencing platform; and Quadris, a data solution that includes multi-data analysis, reporting, and professional service. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was incorporated in 2010 and is headquartered in Culver City, California. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.
VeriSign Inc.
VeriSign, Inc., together with its subsidiaries, provides domain name registry services and internet infrastructure that enables internet navigation for various recognized domain names worldwide. It enables the security, stability, and resiliency of internet infrastructure and services, including providing root zone maintainer services, operating two of the 13 internet root servers; and offering registration services and authoritative resolution for the .com and .net domains, which support global e-commerce. VeriSign, Inc. was incorporated in 1995 and is headquartered in Reston, Virginia.
Latest NH
- SEC Form 15-12G filed by NantHealth Inc.
- NantHealth Inc. filed SEC Form 8-K: Leadership Update
- SEC Form EFFECT filed by NantHealth Inc.
- SEC Form EFFECT filed by NantHealth Inc.
- SEC Form POS AM filed by NantHealth Inc.
- SEC Form POS AM filed by NantHealth Inc.
- SEC Form S-8 POS filed by NantHealth Inc.
- SEC Form S-8 POS filed by NantHealth Inc.
- SEC Form S-8 POS filed by NantHealth Inc.
- NantHealth Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
Latest VRSN
- Exec. Chairman, Pres, & CEO Bidzos D James sold $927,964 worth of shares (3,300 units at $281.20), decreasing direct ownership by 0.79% to 412,939 units (SEC Form 4)
- EVP, Chief Financial Officer Calys John sold $140,778 worth of shares (500 units at $281.56), decreasing direct ownership by 2% to 31,087 units (SEC Form 4)
- DNIB.com Reports Internet Has 401.6 Million Domain Name Registrations at the End of the Second Quarter of 2026
- SEC Form 10-Q filed by VeriSign Inc.
- VeriSign Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
- Verisign Reports Second Quarter 2026 Results
- Verisign Announces Delegation of .Web
- Director Mccann Debra was granted 900 shares, increasing direct ownership by 48% to 2,780 units (SEC Form 4)
- Director Desch Matthew J was granted 900 shares, increasing direct ownership by 124% to 1,628 units (SEC Form 4)
- Director Gorelick Jamie S was granted 900 shares (SEC Form 4)